MARINUS PHARMACEUTICALS, INC. (MRNS) Common Stock, Shares, Issued 2013 - 2024

Historical data

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
Marinus Pharmaceuticals, Inc. quarterly Common Stock, Shares, Issued history and growth rate from 2013 to 2024.
  • Marinus Pharmaceuticals, Inc. Common Stock, Shares, Issued for the quarter ending March 31, 2024 was 54.9M shares, a 10.6% increase year-over-year.
Common Stock, Shares, Issued, Quarterly Data (shares)
Period Value YoY Chg Change % Date Report Filed
Q1 2024 54.9M +5.27M +10.6% Mar 31, 2024 10-Q 2024-05-08
Q4 2023 54.6M +4.94M +9.94% Dec 31, 2023 10-Q 2024-05-08
Q3 2023 54.6M +17.4M +46.7% Sep 30, 2023 10-Q 2023-11-07
Q2 2023 50.6M +13.4M +36% Jun 30, 2023 10-Q 2023-08-10
Q1 2023 49.7M +12.5M +33.7% Mar 31, 2023 10-Q 2023-05-11
Q4 2022 49.7M +12.9M +34.9% Dec 31, 2022 10-K 2024-03-05
Q3 2022 37.2M +445K +1.21% Sep 30, 2022 10-Q 2022-11-07
Q2 2022 37.2M +467K +1.27% Jun 30, 2022 10-Q 2022-08-11
Q1 2022 37.1M +505K +1.38% Mar 31, 2022 10-Q 2022-05-12
Q4 2021 36.8M +212K +0.58% Dec 31, 2021 10-K 2023-03-09
Q3 2021 36.8M +6.18M +20.2% Sep 30, 2021 10-Q 2021-11-09
Q2 2021 36.7M -85.5M -69.9% Jun 30, 2021 10-Q 2021-08-10
Q1 2021 36.6M -50.1M -57.8% Mar 31, 2021 10-Q 2021-05-17
Q4 2020 36.6M +15M +69.2% Dec 31, 2020 10-K 2022-03-24
Q3 2020 30.6M -22M -41.9% Sep 30, 2020 10-Q 2020-11-09
Q2 2020 122M +69.6M +132% Jun 30, 2020 10-Q 2020-08-06
Q1 2020 86.8M +34.2M +65% Mar 31, 2020 10-Q 2020-05-04
Q4 2019 21.6M -30.9M -58.8% Dec 31, 2019 10-K 2021-03-09
Q3 2019 52.6M +12.1M +29.7% Sep 30, 2019 10-Q 2019-11-06
Q2 2019 52.6M +12M +29.7% Jun 30, 2019 10-Q 2019-08-08
Q1 2019 52.6M +12M +29.7% Mar 31, 2019 10-Q 2019-05-01
Q4 2018 52.5M +12M +29.6% Dec 31, 2018 10-K 2020-03-16
Q3 2018 40.6M +94.8K +0.23% Sep 30, 2018 10-Q 2018-10-29
Q2 2018 40.6M +18.1M +80.7% Jun 30, 2018 10-Q 2018-08-03
Q1 2018 40.5M +18.6M +84.7% Mar 31, 2018 10-Q 2018-05-02
Q4 2017 40.5M +20.8M +105% Dec 31, 2017 10-K 2019-03-12
Q3 2017 40.5M +20.7M +105% Sep 30, 2017 10-Q 2017-10-31
Q2 2017 22.4M +2.91M +14.9% Jun 30, 2017 10-Q 2017-08-01
Q1 2017 22M +2.42M +12.4% Mar 31, 2017 10-Q 2017-05-01
Q4 2016 19.7M +314K +1.62% Dec 31, 2016 10-K 2018-03-07
Q3 2016 19.7M +5.37M +37.4% Sep 30, 2016 10-Q 2016-11-08
Q2 2016 19.5M +5.28M +37% Jun 30, 2016 10-Q 2016-08-09
Q1 2016 19.5M +5.31M +37.3% Mar 31, 2016 10-Q 2016-05-02
Q4 2015 19.4M +5.38M +38.3% Dec 31, 2015 10-K 2017-03-13
Q3 2015 14.4M +423K +3.03% Sep 30, 2015 10-Q 2015-10-29
Q2 2015 14.3M +13.7M +2636% Jun 30, 2015 10-Q 2015-08-04
Q1 2015 14.2M Mar 31, 2015 10-Q 2015-05-14
Q4 2014 14M +13.5M +2740% Dec 31, 2014 10-K 2016-03-07
Q3 2014 13.9M Sep 30, 2014 10-Q 2014-11-13
Q2 2014 521K Jun 30, 2014 10-Q/A 2014-10-10
Q4 2013 494K Dec 31, 2013 10-K 2015-03-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.